You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDM2

Showing 1 - 25 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Lung Non-Squamous Non-Small Cell Carcinoma
  • +3 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Sargramostim
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage IB Breast Cancer AJCC v8
  • +16 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Sargramostim
  • Seattle, Washington
  • +1 more
Jul 27, 2022

HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

Recruiting
  • HER2 Negative Breast Carcinoma
  • +6 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 18, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

Recruiting
  • Malignant Salivary Gland Cancer
  • Salivary Gland Cancer
  • Tampa, Florida
  • +2 more
Feb 10, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Myeloma Trial in Houston (DS-3032b)

Terminated
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 13, 2019

Ulcerative Colitis Trial in Worldwide (Adalimumab)

Active, not recruiting
  • Ulcerative Colitis
  • Adalimumab
  • Orlando, Florida
  • +15 more
Jan 20, 2022

Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)

Recruiting
  • Liposarcoma
  • Atypical Lipomatous Tumor
  • Blood sampling
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022

Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

Recruiting
  • Resectable Soft Tissue Sarcoma
  • Soft Tissue Sarcoma
  • Goodyear, Arizona
  • +52 more
Jul 21, 2022

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed
  • Glomerulonephritis, Membranous
  • antiPLA2R Positive
  • Azusa, California
  • +44 more
Dec 12, 2022

Solid Tumors Trial in United States (RAIN-32)

Recruiting
  • Solid Tumors
  • Palo Alto, California
  • +9 more
Aug 16, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

Focal Segmental Glomerulosclerosis (FSGS) Trial in Worldwide (PF-06730512)

Active, not recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Birmingham, Alabama
  • +59 more
Aug 17, 2022

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Goshen, Indiana
  • +44 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

    Completed
    • Gastric Adenocarcinoma
    • Orlando, Florida
    • +80 more
    Jan 13, 2023

    Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia
    • Birmingham, Alabama
    • +25 more
    Mar 4, 2022

    Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Metastatic Soft-tissue Sarcoma
    • Bordeaux, France
    • +4 more
    May 5, 2022

    Engagement Patterns and Participation Trends Among Liposarcoma

    Not yet recruiting
    • Liposarcoma
      • San Francisco, California
        Power Life Sciences
      Sep 8, 2023